NFD Lawsuit News and Information
Nephrogenic Systemic Fibrosis Lawsuit
Gadolinium based contrast agents used during MRI and MRA tests could cause nephrogenic systemic fibrosis (NSF), also known as nephrogenic fibrosing dermopathy (NFD) for individuals with moderate to severe kidney problems. The devastating condition could have been avoided by hundreds of people throughout the United States if the manufacturers of these contrast agents had [...]
All Articles Tagged With: "NFD"
Nephrogenic Systemic Fibrosis Settlements Reached by Bayer in 140 Cases
Bayer reports that it has reached settlement agreements with nearly half of the plaintiffs who have filed a Magnevist lawsuit, involving claims that the company’s gadolinium-based MRI contrasting agent caused users to develop a rare and potentially life-threatening condition, known as nephrogenic systemic fibrosis (NSF).
GE Healthcare Settles Libel Lawsuit Over Omniscan with Radiologist
GE Healthcare and a Danish scientist have reached a settlement in a libel lawsuit over statements made about the side effects of Omniscan, an MRI contrast agent that has been linked to nephrogenic systemic fibrosis (NSF), a severe and debilitating injury.
Radiologist Fights Back Against GE Healthcare Over Omniscan Side Effects
A Danish scientist is filing a counterclaim against GE Healthcare in response to libel charges originally brought by the company over critical statements the radiologist made about potential side effects of Omniscan, an MRI contrast agent that has been linked to a severe and debilitating injury among some patients, known as nephrogenic systemic fibrosis (NSF). [...]
Nephrogenic Systemic Fibrosis Lawsuit Scheduled For Trial in San Francisco
A date has been set for the start of what could be the first trial of a lawsuit involving nephrogenic systemic fibrosis (NSF), a severe and sometimes fatal condition caused by use of gadolinium based MRI contrast agents.
Nephrogenic Systemic Fibrosis Risk 77 Times Higher Among Dialysis Patients
The results of a new study into side effects of gadolinium MRI contrast agents indicates that patients undergoing dialysis are at 77 fold higher risk of contracting nephrogenic systemic fibrosis (NSF), and kidney transplant patients face a 69 fold higher risk of developing the rare and potentially life-threatening condition, which is associated with a hardening [...]
Nephrogenic Systemic Fibrosis Warnings to be Reviewed Again by FDA
An FDA advisory committee is planning to review a decision by the agency to place the same warning on all gadolinium-based MRI contrast agents about the risk of nephrogenic systemic fibrosis (NSF), as reports suggest that GE Healthcare’s Omniscan (gadodiamide) may be associated with a much greater risk for the debilitating and potentially life-threatening condition. [...]
Gadolinium MRA Contrast Agent Approved by FDA with Warnings about Nephrogenic Systemic Fibrosis
The FDA has approved a new gadolinium-based contrast agent, Vasovist Injection, which is the first imaging agent approved for use during Magnetic Resonance Imaging (MRA) examinations.
Gadolinium Lawyers to Select from 193 NSF Lawsuits for First Trials
Lawyers for the plaintiffs and lawyers for the manufacturers of gadolinium based MRI contract agents, have filed a joint list of 193 NSF lawsuits which are eligible to be among the first cases prepared for trial in the consolidated federal litigation.
Gadolinium Lawyers Set to Meet with Court about Product Identification and Trial Selection
Lawyers involved in the federal litigation over gadolinium-based contrast agents, which have been linked to the development of a debilitating condition known as Nephrogenic Systemic Fibrosis, are scheduled to meet with the Court today to discuss the process for selecting the first NSF lawsuits for trial and the status of the plaintiffs’ ability to identify [...]
Contact a Lawyer
Submit information about your potential case to be reviewed by an attorney.
